ArticleMolecular therapy oncolytics2015

Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity.

Jennifer L Leddon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.